[Endocarditis due to Stenotrophomonas maltophilia].
Candel
Francisco Javier
FJ
López
R
R
Valdivia
A
A
Núñez
M J
MJ
Roca-Arbonés
V
V
Picazo de la Garza
J J
JJ
D001022:Aortic Valve Insufficiency / Q000150:complications; D004198:Disease Susceptibility; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000209:etiology / Q000382:microbiology*; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000382:microbiology*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications; D009055:Mouth / Q000382:microbiology; D015242:Ofloxacin / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000150:complications; D012307:Risk Factors; D020615:Stenotrophomonas maltophilia / Q000302:isolation & purification*; D015819:Substance Abuse, Intravenous; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015242:Ofloxacin